Search Results - "Weber, Randal S."

Organ Preservation for Advanced Larynx Cancer: Issues and Outcomes by Forastiere, Arlene A, Weber, Randal S, Trotti, Andy

“…To provide a review of the clinical data, controversies, and limitations that underpin current recommendations for approaches to larynx preservation for…”
Get full text

Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer by FORASTIERE, ArleneA, QIANGZHANG, THORSTAD, Wade, WAGNER, Henry, ENSLEY, John F, COOPER, Jay S, WEBER, Randal S, MAOR, Moshe H, GOEPFERT, Helmuth, PAJAK, Thomas F, MORRISON, William, GLISSON, Bonnie, TROTTI, Andy, RIDGE, John A

“…To report the long-term results of the Intergroup Radiation Therapy Oncology Group 91-11 study evaluating the contribution of chemotherapy added to radiation…”
Get full text

Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis by MACHTAY, Mitchell, MOUGHAN, Jennifer, TROTTI, Andrew, GARDEN, Adam S, WEBER, Randal S, COOPER, Jay S, FORASTIERE, Arlene, KIAN ANG, K

“…Concurrent chemoradiotherapy (CCRT) for squamous cell carcinoma of the head and neck (SCCHN) increases both local tumor control and toxicity. This study…”
Get full text

Comprehensive Analysis of the MYB-NFIB Gene Fusion in Salivary Adenoid Cystic Carcinoma: Incidence, Variability, and Clinicopathologic Significance by MITANI, Yoshitsugu, JIE LI, RAO, Pulivarthi H, ZHAO, Yi-Jue, BELL, Diana, LIPPMAN, Scott M, WEBER, Randal S, CAULIN, Carlos, EL-NAGGAR, Adel K

“…The objectives of this study were to determine the incidence of the MYB-NFIB fusion in salivary adenoid cystic carcinoma (ACC), to establish the…”
Get full text

Multifield Optimization Intensity Modulated Proton Therapy for Head and Neck Tumors: A Translation to Practice by Frank, Steven J., MD, Cox, James D., MD, Gillin, Michael, PhD, Mohan, Radhe, PhD, Garden, Adam S., MD, Rosenthal, David I., MD, Gunn, G. Brandon, MD, Weber, Randal S., MD, Kies, Merrill S., MD, Lewin, Jan S., PhD, Munsell, Mark F., MS, Palmer, Matthew B., BS, Sahoo, Narayan, PhD, Zhang, Xiaodong, PhD, Liu, Wei, PhD, Zhu, X. Ronald, PhD

“…Background We report the first clinical experience and toxicity of multifield optimization (MFO) intensity modulated proton therapy (IMPT) for patients with…”
Get full text

Pan-Trk immunohistochemistry reliably identifies ETV6-NTRK3 fusion in secretory carcinoma of the salivary gland by Bell, Diana, Ferrarotto, Renata, Liang, Li, Goepfert, Ryan P., Li, Jie, Ning, Jing, Broaddus, Russell, Weber, Randal S., El-Naggar, Adel K.

“…Secretory carcinoma of the salivary gland is a newly recognized entity that morphologically resembles breast secretory carcinoma and has a characteristic…”
Get full text

Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity‐modulated radiotherapy by Pan, Jian Ji, Ng, Wai Tong, Zong, Jing Feng, Lee, Sarah W. M., Choi, Horace C. W., Chan, Lucy L. K., Lin, Shao Jun, Guo, Qiao Juan, Sze, Henry C. K., Chen, Yun Bin, Xiao, You Ping, Kan, Wai Kuen, O'Sullivan, Brian, Xu, Wei, Le, Quynh Thu, Glastonbury, Christine M., Colevas, A. Dimitrios, Weber, Randal S., Lydiatt, William, Shah, Jatin P., Lee, Anne W. M.

“…BACKGROUND The objective of this study was to develop a nomogram for refining prognostication for patients with nondisseminated nasopharyngeal cancer (NPC)…”
Get full text

Validation of NRG oncology/RTOG‐0129 risk groups for HPV‐positive and HPV‐negative oropharyngeal squamous cell cancer: Implications for risk‐based therapeutic intensity trials by Fakhry, Carole, Zhang, Qiang, Gillison, Maura L., Nguyen‐Tân, Phuc Felix, Rosenthal, David I., Weber, Randal S., Lambert, Louise, Trotti, Andy M., Barrett, William L., Thorstad, Wade L., Yom, Sue S., Wong, Stuart J., Ridge, John A., Rao, Shyam S. D., Spencer, Sharon, Fortin, Andre, Raben, David, Harris, Jonathan, Le, Quynh‐Thu

“…Background Radiation Therapy Oncology Group (RTOG)‐0129 recursive partitioning analysis was the basis for risk‐based therapeutic intensification trials for…”
Get full text

National Cancer Database report on cancer of the head and neck: 10-Year update by Cooper, Jay S., Porter, Kim, Mallin, Katherine, Hoffman, Henry T., Weber, Randal S., Ang, Kian K., Gay, E. Greer, Langer, Corey J.

“…Background We sought to examine the current state of cancer care for head and neck tumors in the United States. We therefore performed a retrospective,…”
Get full text

Prognostic factors in mucoepidermoid carcinoma of the salivary glands by McHugh, Catherine H., Roberts, Dianna B., El‐Naggar, Adel K., Hanna, Ehab Y., Garden, Adam S., Kies, Merrill S., Weber, Randal S., Kupferman, Michael E.

“…BACKGROUND: Mucoepidermoid carcinoma (MEC) is the most common malignancy of the major salivary glands. Prior reports noted histological grade and tumor stage…”
Get full text

CpG island methylation profiling in human salivary gland adenoid cystic carcinoma by Bell, Achim, Bell, Diana, Weber, Randal S., El‐Naggar, Adel K.

“…BACKGROUND: DNA methylation is a fundamental epigenetic event associated with physiologic and pathologic conditions, including cancer. Hypermethylation of CpG…”
Get full text

Prognosis and risk factors for early‐stage adenoid cystic carcinoma of the major salivary glands by Bhayani, Mihir K., Yener, Murat, El‐Naggar, Adel, Garden, Adam, Hanna, Ehab Y., Weber, Randal S., Kupferman, Michael E.

“…BACKGROUND: Adenoid cystic carcinoma (ACC) is characterized by slow growth, frequent local recurrences, and distant metastasis (DM). However, these findings…”
Get full text

A Phase II Study of Gefitinib for Aggressive Cutaneous Squamous Cell Carcinoma of the Head and Neck by LEWIS, Carol M, GLISSON, Bonnie S, WEBER, Randal S, LEI FENG, FIONA WAN, XIMING TANG, WISTUBA, Ignacio I, EL-NAGGAR, Adel K, ROSENTHAL, David I, CHAMBERS, Mark S, LUSTIG, Robert A

“…To determine the disease control rate and toxicity of treating patients with aggressive cutaneous squamous cell carcinoma (CSCC) with neoadjuvant gefitinib. A…”
Get full text

Delay to surgery after neoadjuvant chemotherapy in head and neck squamous cell carcinoma affects oncologic outcomes by Kiong, Kimberley L., Yao, Christopher M. K. L., Lin, Fang‐Yu, Bell, Diana, Ferrarotto, Renata, Weber, Randal S., Lewis, Carol M.

“…Background Neoadjuvant chemotherapy (NAC) is used in head and neck squamous cell carcinoma (HNSCC) for downstaging advanced disease and decreasing distant…”
Get full text

Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Standard Radiation Versus Accelerated Radiation Plus Cisplatin for Locally Advanced Head and Neck Carcinoma: NRG Oncology RTOG 0129 by Xiao, Canhua, PhD, Zhang, Qiang, PhD, Nguyen-Tân, Phuc Felix, MD, List, Marcie, PhD, Weber, Randal S., MD, Ang, K. Kian, MD, Rosenthal, David, MD, Filion, Edith J., MD, Kim, Harold, MD, Silverman, Craig, MD, Raben, Adam, MD, Galloway, Thomas, MD, Fortin, Andre, MD, Gore, Elizabeth, MD, Winquist, Eric, MD, MSc, Jones, Christopher U., MD, Robinson, William, MD, Raben, David, MD, Le, Quynh-Thu, MD, Bruner, Deborah, RN, PhD

“…Purpose/Objective(s) To analyze quality of life (QOL) and performance status (PS) for head and neck cancer (HNC) patients treated on NRG Oncology RTOG 0129 by…”
Get full text

Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapy by Saintigny, Pierre, Mitani, Yoshitsugu, Pytynia, Kristen B., Ferrarotto, Renata, Roberts, Dianna B., Weber, Randal S., Kies, Merrill S., Maity, Sankar N., Lin, Sue‐Hwa, El‐Naggar, Adel K.

“…BACKGROUND Patients with advanced primary and recurrent salivary duct carcinoma (SDC), a rare and lethal malignancy, have limited therapeutic options. Novel…”
Get full text

Primary intraosseous mucoepidermoid carcinoma of the jaw: Reappraisal of The MD Anderson Cancer Center experience by Bell, Diana, Lewis, Carol, El-Naggar, Adel K., Weber, Randal S.

“…Background Mucoepidermoid carcinoma arises from major or minor salivary glands, making up 10% of salivary gland tumors. Intraosseous mucoepidermoid carcinomas…”
Get full text

Genetic and expression analysis of HER-2 and EGFR genes in salivary duct carcinoma: empirical and therapeutic significance by Williams, Michelle D, Roberts, Dianna B, Kies, Merrill S, Mao, Li, Weber, Randal S, El-Naggar, Adel K

“…Salivary duct carcinoma overexpresses epidermal growth factor receptor (EGFR) and HER-2, although the underlying mechanisms remain undefined. Because of the…”
Get full text

Multidisciplinary Team Planning for Patients with Head and Neck Cancer by Shellenberger, Thomas D., DMD, MD, Weber, Randal S., MD

“…The multidisciplinary team planning conference is critical in the evaluation and management of patients with head and neck cancer. The management is complex…”
Get full text

Cerebrovascular Disease Risk in Older Head and Neck Cancer Patients After Radiotherapy by SMITH, Grace L, SMITH, Benjamin D, BUCHHOLZ, Thomas A, GIORDANO, Sharon H, GARDEN, Adam S, WOODWARD, Wendy A, KRUMHOLZ, Harlan M, WEBER, Randal S, ANG, K.-Kian, ROSENTHAL, David I

“…Cerebrovascular disease is common in head and neck cancer patients, but it is unknown whether radiotherapy increases the cerebrovascular disease risk in this…”
Get full text